Five filters. One signal.
Our disciplined approach focuses on companies with demonstrated product readiness, strong technical leadership, and scalable solutions in healthcare innovation.
Where conviction is built — quietly, deliberately, in the room.
Geography
Global mandate with sharp focus on India-based companies or Indian-origin founders. Expanding into Africa via our upcoming SPAC.
Time
We invest post-product readiness and initial market validation — typically Series A and beyond.
People
Exceptional founders with conviction, depth, and at least one technical co-founder.
Cheque Size
Minimum US$ 10 Million — meaningful capital to accelerate growth and earn deep partnership.
Industry
Healthcare, HealthTech, Drug Discovery, Pharma Manufacturing, MedTech, Device Technology, and AI for Computer-Aided Drug Discovery (CADD).
Portfolio construction.
- —Diversified across scientific modalities to mitigate single-technology risk.
- —Capped at 25 companies per fund for concentrated attention and follow-on capacity.
- —Strong governance combined with founder-friendly structures.